IFNA1 and plasma cell myeloma: Subsequently, we treated myeloma cells with doxorubicin(0.8μM), IFN-α(2000U/ml), doxorubicin(0.4μM) + IFN-α(1000U/ml) for 24 hours and 48 hours, respectively.